Steven B Ratoff - Net Worth and Insider Trading

Steven B Ratoff Net Worth

The estimated net worth of Steven B Ratoff is at least $51,897 dollars as of 2024-09-24. Steven B Ratoff is the Director of Eagle Pharmaceuticals Inc and owns about 13,324 shares of Eagle Pharmaceuticals Inc (EGRX) stock worth over $51,897. Details can be seen in Steven B Ratoff's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Steven B Ratoff has not made any transactions after 2016-12-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Steven B Ratoff

To

Steven B Ratoff Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Steven B Ratoff owns 3 companies in total, including Eagle Pharmaceuticals Inc (EGRX) , NovaDel Pharma Inc (NVDL) , and Raptor Pharmaceutical Corp (RPTP) .

Click here to see the complete history of Steven B Ratoff’s form 4 insider trades.

Insider Ownership Summary of Steven B Ratoff

Ticker Comapny Transaction Date Type of Owner
EGRX Eagle Pharmaceuticals Inc 2016-12-13 director
NVDL NovaDel Pharma Inc 2009-12-31 director & President and CEO
RPTP Raptor Pharmaceutical Corp 2008-06-19 director

Steven B Ratoff Latest Holdings Summary

Steven B Ratoff currently owns a total of 1 stock. Steven B Ratoff owns 13,324 shares of Eagle Pharmaceuticals Inc (EGRX) as of December 13, 2016, with a value of $51,897.

Latest Holdings of Steven B Ratoff

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EGRX Eagle Pharmaceuticals Inc 2016-12-13 13,324 3.90 51,897

Holding Weightings of Steven B Ratoff


Steven B Ratoff Form 4 Trading Tracker

According to the SEC Form 4 filings, Steven B Ratoff has made a total of 0 transactions in Eagle Pharmaceuticals Inc (EGRX) over the past 5 years. The most-recent trade in Eagle Pharmaceuticals Inc is the sale of 10,000 shares on December 13, 2016, which brought Steven B Ratoff around $750,100.

Insider Trading History of Steven B Ratoff

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Steven B Ratoff Trading Performance

GuruFocus tracks the stock performance after each of Steven B Ratoff's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steven B Ratoff is 8.4%. GuruFocus also compares Steven B Ratoff's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steven B Ratoff within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Steven B Ratoff's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Steven B Ratoff

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -25.8 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -25.4 LIMIT LIMIT LIMIT LIMIT LIMIT

Steven B Ratoff Ownership Network

Ownership Network List of Steven B Ratoff

No Data

Ownership Network Relation of Steven B Ratoff

Insider Network Chart

Steven B Ratoff Owned Company Details

What does Eagle Pharmaceuticals Inc do?

Who are the key executives at Eagle Pharmaceuticals Inc?

Steven B Ratoff is the director of Eagle Pharmaceuticals Inc. Other key executives at Eagle Pharmaceuticals Inc include director & President and CEO Scott Tarriff , EVP & Chief Commercial Officer Michael Shawn Moran , and Chief Medical Officer Judith Ng-cashin .

Eagle Pharmaceuticals Inc (EGRX) Insider Trades Summary

Over the past 18 months, Steven B Ratoff made no insider transaction in Eagle Pharmaceuticals Inc (EGRX). Other recent insider transactions involving Eagle Pharmaceuticals Inc (EGRX) include a net sale of 101,864 shares made by Scott Tarriff ,

In summary, during the past 3 months, insiders sold 0 shares of Eagle Pharmaceuticals Inc (EGRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 101,864 shares of Eagle Pharmaceuticals Inc (EGRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 101,864 shares.

Eagle Pharmaceuticals Inc (EGRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Eagle Pharmaceuticals Inc Insider Transactions

No Available Data

Steven B Ratoff Mailing Address

Above is the net worth, insider trading, and ownership report for Steven B Ratoff. You might contact Steven B Ratoff via mailing address: 5291 N Camino Sw, Tuscon Az 85718.

Discussions on Steven B Ratoff

No discussions yet.